MD1003 (High-Dose Pharmaceutical-Grade Biotin) for the Treatment of Chronic Visual Loss Related to Optic Neuritis in Multiple Sclerosis: A Randomized, Double-Blind, Placebo-Controlled Study

Tourbah, A; Gout, O; Vighetto, A; Deburghgraeve, V; Pelletier, J; Papeix, C; Lebrun-Frenay, C; ... Arndt, C; + view all Tourbah, A; Gout, O; Vighetto, A; Deburghgraeve, V; Pelletier, J; Papeix, C; Lebrun-Frenay, C; Labauge, P; Brassat, D; Toosy, A; Laplaud, D-A; Outteryck, O; Moreau, T; Debouverie, M; Clavelou, P; Heinzlef, O; De Seze, J; Defer, G; Sedel, F; Arndt, C; - view fewer (2018) MD1003 (High-Dose Pharmaceutical-Grade Biotin) for the Treatment of Chronic Visual Loss Related to Optic Neuritis in Multiple Sclerosis: A Randomized, Double-Blind, Placebo-Controlled Study. CNS Drugs , 32 (7) pp. 661-672. 10.1007/s40263-018-0528-2 . Green open access

https://ift.tt/2Qm839W